CONTRAINDICATIONS According to the package insert, Mounjaro and Zepbound is contraindicated in patients with the following: personal or family history of Medullary Thyroid Carcinoma patients with Multiple Endocrine Neoplasm type 2 patients with a prior serious hypersensitivity reaction to tirzepatide or to any of the excipients in Mounjaroand Zepbound
B12 deficiency symptoms, including fatigue, weakness, numbness in extremities, cognitive fog, and mood changes, can mimic or worsen common semaglutide side effects
Avoid drinking large amounts with meals, as this worsens fullness and nausea
Reducing Stored Fat Niacinamide, in conjunction with Tirzepatide, promotes the breakdown of fats for energy production
Trava is transparent about this distinction